Darryl D. Dixon

发表

Practical radical cyclizations with arylboronic acids and trifluoroborates.

P. Baran, J. Lockner, Jonathan W Lockner, 2011, Organic letters.

C-H functionalization logic enables synthesis of (+)-hongoquercin A and related compounds.

Peter S. Thuy-Boun, P. Baran, jin-quan yu, 2013, Angewandte Chemie.

A Simple Procedure for C-C Bond Cleavage of Aromatic and Aliphatic Epoxides with Aqueous Sodium Periodate Under Ambient Conditions.

M. Tius, B. Singaram, Darryl D. Dixon, 2008, Tetrahedron letters.

A Mild, Functional Group Tolerant Addition of Organozinc Nucleophiles to N-Activated Quinolines and Isoquinolines.

Martin D. Eastgate, Michael A. Schmidt, A. Ortiz, 2017, The Journal of organic chemistry.

The Evolution of the Total Synthesis of Rocaglamide.

M. Tius, Anais Jolit, Zhe Zhou, 2016, Chemistry.

Practical and innate C–H functionalization of heterocycles

N. Sach, P. Baran, M. Collins, 2012, Nature.

A new reagent for direct difluoromethylation.

D. Blackmond, P. Baran, M. Collins, 2012, Journal of the American Chemical Society.

An efficient copper-catalyzed coupling reaction of pyridin-2-ones with aryl and heterocyclic halides based on Buchwald's protocol

Darryl D Dixon, C. Li, Darryl D. Dixon, 2004 .

An Efficient Copper‐Catalyzed Coupling Reaction of Pyridin‐2‐ones with Aryl and Heterocyclic Halides Based on Buchwald′s Protocol.

C. Li, Darryl D. Dixon, 2004 .

Redox-Active Esters in Fe-Catalyzed C–C Coupling

P. Baran, Gardner S. Creech, L. Wimmer, 2016, Journal of the American Chemical Society.

Direct Lewis Acid Catalyzed Conversion of Enantioenriched N-Acyloxazolidinones to Chiral Esters, Amides, and Acids.

Jason M. Stevens, J. Janey, G. Beutner, 2018, The Journal of organic chemistry.

Practical radical cyclizations with arylboronic acids and trifluoroborates.

P. Baran, J. Lockner, Rune Risgaard, 2011, Organic letters.

Mixed Aggregates of 1-Methoxyallenyllithium with Lithium Chloride

M. Tius, L. M. Pratt, Darryl D. Dixon, 2014, ChemistryOpen.

Heteroadamantyl cannabinoids.

Anna L. Bowman, M. Tius, J. Wood, 2010, Journal of medicinal chemistry.

Scalable, divergent synthesis of meroterpenoids via "borono-sclareolide".

P. Baran, Darryl D Dixon, J. Lockner, 2012, Journal of the American Chemical Society.

Process Development and Scale-Up of a Protease Inhibitor for the Treatment of HIV Featuring the Preparation of a Neopentyl Grignard Reagent and Development of a One-Pot Curtius Reaction

W. Lew, Q. Wang, M. A. Ischay, 2022, Organic Process Research & Development.

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.

Bin Wang, Rui Xu, Zhaodan Cao, 2016, Cancer research.

3-[(1 S,2 S,3 R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma.

Paul M Wehn, Keshi Wang, G. Han, 2019, Journal of medicinal chemistry.

Safe Scale-up of an Oxygen-Releasing Cleavage of Evans Oxazolidinone with Hydrogen Peroxide

Fulya Akpinar, G. Beutner, Andrew W. Glace, 2020 .

Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor

Jason M. Stevens, Miao Yu, Michael A. Schmidt, 2019, Organic Process Research & Development.

C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.

Anna L. Bowman, M. Tius, Han Zhou, 2012, Bioorganic & medicinal chemistry letters.

Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385).

Z. Cao, Tzuling Cheng, Paul M Wehn, 2018, Journal of medicinal chemistry.

Revisiting the Cleavage of Evans Oxazolidinones with LiOH/H2O2

Jason M. Stevens, G. Beutner, Andrew W. Glace, 2019, Organic Process Research & Development.

A new reagent for direct difluoromethylation.

D. Blackmond, P. Baran, M. Collins, 2012, Journal of the American Chemical Society.

A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.

Z. Cao, Tzuling Cheng, Keshi Wang, 2016, Cancer research.